Is Banner Display?
Off
Page Content
#ffffff

Replacing artificial sweetened beverages with water did not improve glycemic control in adults with T2DM. The study, published in Diabetes Care, evaluated whether substituting plain water for habitual ASB intake would improve diabetes-related outcomes.

The randomized, two-arm trial enrolled 181 adults with T2DM aged 35 years or older who regularly consumed ASBs and had baseline HbA1c between 6.5% and 8.5%. Participants consumed 24 ounces daily of either a commercial ASB or unflavored water for 24 weeks after a 2-week run-in period. Outcomes were assessed at baseline, 12 weeks, and 24 weeks.

At 24 weeks, the mean change in HbA1c was 0.29% higher in the water group compared with the ASB group (SE 0.12; P = 0.013). Secondary measures showed no significant differences between groups but aligned directionally with HbA1c findings.

These results indicate that substituting water for ASBs does not improve glycemic measures or related clinical outcomes over 24 weeks in individuals with T2DM.

Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Key highlights
  • Glycated hemoglobin (HbA1c) did not improve when water replaced artificial sweetened beverages (ASBs).
  • Fructosamine, fasting glucose, insulin, body weight, and continuous glucose monitoring metrics showed no significant differences.
  • Water substitution did not improve diabetes-related clinical outcomes in adults with type 2 diabetes mellitus (T2DM).
Source

Odegaard AO, Chang J, Jiang L, et al. The Effect of Substituting Water for Artificially Sweetened Beverages on Glycemic and Weight Measures in People With Type 2 Diabetes: The Study of Drinks With Artificial Sweeteners (SODAS), a Randomized Trial. Diabetes Care. Published online December 10, 2025. doi:10.2337/dc25-1516

Thumbnail
Replacing Artificial Sweetened Drinks with Water Fails to Improve HbA1c in T2DM
Schedule Date & Time
Speciality
Currency
Sub Sub Speciality
Short Description

Substituting water for artificial sweetened beverages does not improve HbA1c or related clinical outcomes over 24 weeks

Release Date
Is Paid
0
Send Notification
Off